Nazanin Bashiri

CARRPO – Copenhagen arterial revascularization randomized patency and outcome trial: Arterial revascularization for coronary bypass surgery: A randomized trial comparing the outcome after using LIMA + vein grafts versus total arterial revascularization with LIMA + RIMA + radial artery grafts. Start year: 2002

Clinical Trial Posts / By

CARRPO Official title: Copenhagen arterial revascularization randomized patency and outcome trial: Arterial revascularization for coronary bypass surgery: A randomized trial comparing the outcome after using LIMA + vein grafts versus total arterial revascularization with LIMA + RIMA + radial artery graftsTrial start year: 2002 Trial websiteNo website available Trial registrationNCT00159991View registration Design paperNo design paper …

CARRPO – Copenhagen arterial revascularization randomized patency and outcome trial: Arterial revascularization for coronary bypass surgery: A randomized trial comparing the outcome after using LIMA + vein grafts versus total arterial revascularization with LIMA + RIMA + radial artery grafts. Start year: 2002 Read More »

POISE-I – Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery. Start year: 2002

Clinical Trial Posts / By

POISE-I Official title: Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgeryTrial start year: 2002 Trial websiteNo website available Trial registrationNCT00182039View registration Design paper2001Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) Trial: A randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgeryDownload full paper Result paper2008Eff ects of extended-release …

POISE-I – Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery. Start year: 2002 Read More »

Gluud C, Kjaergard LL. Quality of randomized clinical trials in portal hypertension and other fields of hepatology. In: de Franchies R, ed. Portal Hypertension III: Proceedings of the Third Baveno International Consensus Workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell Science Ltd. 2001: 204-18.

Books and Documentaries / By

Gluud C, Kjaergard LL. Quality of randomized clinical trials in portal hypertension and other fields of hepatology. In: de Franchies R, ed. Portal Hypertension III: Proceedings of the Third Baveno International Consensus Workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell Science Ltd. 2001: 204-18. Unfortunately, no direct link available.

Gluud C. Alcoholic hepatitis: no glucocorticosteroids? In: Leuschner U, James O, Dancygier H, eds. Steatohepatitis (NASH and ASH) – Falk Symposium 121. Dordrecht: Kluwer Academic Publishers. 2001: (36); 322-42.

Leave a Comment / Books and Documentaries / By

Gluud C. Alcoholic hepatitis: no glucocorticosteroids? In: Leuschner U, James O, Dancygier H, eds. Steatohepatitis (NASH and ASH) – Falk Symposium 12. Dordrecht: Kluwer Academic Publishers. 2001: (36); 322-42. Unfortunately, no direct link available.

ADDITION – Anglo-danish-dutch study of intensive treatment in people with screen detected diabetes in primary care. Start year: 2001

Clinical Trial Posts / By

ADDITION Official title: Anglo-danish-dutch study of intensive treatment in people with screen detected diabetes in primary careTrial start year: 2001 Trial websitewww.addition.au.dk/View website Trial registrationNCT00237549View registration Design paper2000The ADDITION{ study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screeningDownload full paper …

ADDITION – Anglo-danish-dutch study of intensive treatment in people with screen detected diabetes in primary care. Start year: 2001 Read More »

NMSG8 – Aredia Myelom – The effect of i.v. bisphosphonate on health-related quality of life and skeletal morbidity for newly diagnosed treatment demanding multiple myeloma. A prospective randomised double blinded dose-effective study with cost-utility analysis. Start year: 2001

Clinical Trial Posts / By

NMSG8 – Aredia Myelom Official title: The effect of i.v. bisphosphonate on health-related quality of life and skeletal morbidity for newly diagnosed treatment demanding multiple myeloma. A prospective randomised double blinded dose-effective study with cost-utility analysisTrial start year: 2001 Trial websiteNo website available Trial registrationNCT00376883View registration Design paperNo design paper published Result paper2010Eff ect of …

NMSG8 – Aredia Myelom – The effect of i.v. bisphosphonate on health-related quality of life and skeletal morbidity for newly diagnosed treatment demanding multiple myeloma. A prospective randomised double blinded dose-effective study with cost-utility analysis. Start year: 2001 Read More »

NMSG12 – Thalidomid. A phase 3 study with randomization to Melphalan/Prednisone/Thalidomide versus Melphalan/Prednisone/Placebo to patients with previously untreated multiple myeloma. Start year: 2001

Clinical Trial Posts / By

NMSG12 – Thalidomid Official title: A phase 3 study with randomization to Melphalan/Prednisone/Thalidomide versus Melphalan/Prednisone/Placebo to patients with previously untreated multiple myelomaTrial start year: 2001 Trial websiteNo website available Trial registrationNCT00218855View registration Design paperNo design paper published Result paper2010Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myelomaDownload full paper

KATHY – Cognitive-behavioural therapy versus short-term psychodynamic psychotherapy: a randomised clinical trial. Start year: 2001

Clinical Trial Posts / By

KATHY Official title: Cognitive-behavioural therapy versus short-term psychodynamic psychotherapy: a randomised clinical trialTrial start year: 2001 Trial websiteNo website available Trial registrationNCT00208247View registration Design paperNo design paper published Result paper2010A randomized clinical trial of cognitive behavioural therapy versus short-­ term psychodynamic psychotherapy versus no intervention for patients with hypochondriasisDownload full paper